Search Query :
2WMX
Crystal structure of checkpoint kinase 1 (chk1) in complex with inhibitors Deposition Author(s): Aherne, G.W. , Boxall, K. , Burns, S. , Cherry, M. , Cheung, K.-M.J. , Collins, I. , Fisher, M. , Garrett, M.D. , Klair, S. , Matthews, T.P. , Mchardy, T. , Reader, J. , Van Montfort, R. , Walton, M.I. , Westwood, I.M. , Williams, D.
Date: 2009-07-03 Method: X-RAY DIFFRACTION Resolution: 2.45 Å Organism(s): Homo Sapiens Sequences Data: 2WMX_A
2XEY
Crystal structure of checkpoint kinase 1 (chk1) in complex with inhibitors Deposition Author(s): Addison, G.J. , Aherne, G.W. , Allen, C.E. , Boxall, K. , Cherry, M. , Collins, I. , Ellard, J. , Fisher, M. , Garrett, M.D. , Klair, S. , Matthews, T.P. , Mchardy, T. , Reader, J.C. , Van Montfort, R. , Westwood, I.M.
Date: 2010-05-19 Method: X-RAY DIFFRACTION Resolution: 2.7 Å Organism(s): Homo Sapiens Sequences Data: 2XEY_A
2XF0
Crystal structure of checkpoint kinase 1 (chk1) in complex with inhibitors Deposition Author(s): Addison, G.J. , Aherne, G.W. , Allen, C.E. , Boxall, K. , Cherry, M. , Collins, I. , Ellard, J. , Fisher, M. , Garrett, M.D. , Klair, S. , Matthews, T.P. , Mchardy, T. , Reader, J.C. , Van Montfort, R. , Westwood, I.M.
Date: 2010-05-19 Method: X-RAY DIFFRACTION Resolution: 2.4 Å Organism(s): Homo Sapiens Sequences Data: 2XF0_A
4C4E
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 Deposition Author(s): Atrash, B. , Baker, R. , Bavetsias, V. , Blagg, J. , Boxall, K. , Burke, R. , Choi, V. , De Haven Brandon, A. , Eccles, S.A. , Faisal, A. , Gurden, M. , Hayes, A. , Henley, A. , Linardopoulos, S. , Liu, M. , Mak, G. , Matijssen, B. , Mcandrew, C. , Naud, S. , Raynaud, F.I. , Schmitt, J. , Sheldrake, P. , Valenti, M. , Van Montfort, R. , Westwood, I.M. , Wood, A.
Date: 2013-09-05 Method: X-RAY DIFFRACTION Resolution: 2.6 Å Organism(s): Homo Sapiens Sequences Data: 4C4E_A
4C4F
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 Deposition Author(s): Atrash, B. , Baker, R. , Bavetsias, V. , Blagg, J. , Boxall, K. , Burke, R. , Choi, V. , De Haven Brandon, A. , Eccles, S.A. , Faisal, A. , Gurden, M. , Hayes, A. , Henley, A. , Linardopoulos, S. , Liu, M. , Mak, G. , Matijssen, B. , Mcandrew, C. , Naud, S. , Raynaud, F.I. , Schmitt, J. , Sheldrake, P. , Valenti, M. , Van Montfort, R. , Westwood, I.M. , Wood, A.
Date: 2013-09-05 Method: X-RAY DIFFRACTION Resolution: 2.36 Å Organism(s): Homo Sapiens Sequences Data: 4C4F_A
4C4G
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 Deposition Author(s): Atrash, B. , Baker, R. , Bavetsias, V. , Blagg, J. , Boxall, K. , Burke, R. , Choi, V. , De Haven Brandon, A. , Eccles, S.A. , Faisal, A. , Gurden, M. , Hayes, A. , Henley, A. , Linardopoulos, S. , Liu, M. , Mak, G. , Matijssen, B. , Mcandrew, C. , Naud, S. , Raynaud, F.I. , Schmitt, J. , Sheldrake, P. , Valenti, M. , Van Montfort, R. , Westwood, I.M. , Wood, A.
Date: 2013-09-05 Method: X-RAY DIFFRACTION Resolution: 2.65 Å Organism(s): Homo Sapiens Sequences Data: 4C4G_A
4C4H
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 Deposition Author(s): Atrash, B. , Baker, R. , Bavetsias, V. , Blagg, J. , Boxall, K. , Burke, R. , Choi, V. , De Haven Brandon, A. , Eccles, S.A. , Faisal, A. , Gurden, M. , Hayes, A. , Henley, A. , Linardopoulos, S. , Liu, M. , Mak, G. , Matijssen, B. , Mcandrew, C. , Naud, S. , Raynaud, F.I. , Schmitt, J. , Sheldrake, P. , Valenti, M. , Van Montfort, R. , Westwood, I.M. , Wood, A.
Date: 2013-09-05 Method: X-RAY DIFFRACTION Resolution: 2.8 Å Organism(s): Homo Sapiens Sequences Data: 4C4H_A
4C4I
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 Deposition Author(s): Atrash, B. , Baker, R. , Bavetsias, V. , Blagg, J. , Boxall, K. , Burke, R. , Choi, V. , De Haven Brandon, A. , Eccles, S.A. , Faisal, A. , Gurden, M. , Hayes, A. , Henley, A. , Linardopoulos, S. , Liu, M. , Mak, G. , Matijssen, B. , Mcandrew, C. , Naud, S. , Raynaud, F.I. , Schmitt, J. , Sheldrake, P. , Valenti, M. , Van Montfort, R. , Westwood, I.M. , Wood, A.
Date: 2013-09-05 Method: X-RAY DIFFRACTION Resolution: 2.65 Å Organism(s): Homo Sapiens Sequences Data: 4C4I_A
4C4J
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 Deposition Author(s): Atrash, B. , Baker, R. , Bavetsias, V. , Blagg, J. , Boxall, K. , Burke, R. , Choi, V. , De Haven Brandon, A. , Eccles, S.A. , Faisal, A. , Gurden, M. , Hayes, A. , Henley, A. , Linardopoulos, S. , Liu, M. , Mak, G. , Matijssen, B. , Mcandrew, C. , Naud, S. , Raynaud, F.I. , Schmitt, J. , Sheldrake, P. , Valenti, M. , Van Montfort, R. , Westwood, I.M. , Wood, A.
Date: 2013-09-05 Method: X-RAY DIFFRACTION Resolution: 2.5 Å Organism(s): Homo Sapiens Sequences Data: 4C4J_A
5AP6
Naturally occurring mutations in the mps1 gene predispose cells to kinase inhibitor drug resistance. Deposition Author(s): Blagg, J. , Boxall, K. , Burke, R. , Cheung, K.M. , Faisal, A. , Gurden, M.D. , Hoelder, S. , Linardopoulos, S. , Mak, G. , Mcandrew, C. , Naud, S. , Schmitt, J. , Van Montfort, R. , Westwood, I.M. , Wood, A. , Workman, P.
Date: 2015-09-14 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Homo Sapiens Sequences Data: 5AP6_A